Inflammation
Showing NaN - NaN of 4
Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))
Recruiting
- Cardiovascular Risk
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Birmingham, Alabama
- +768 more
Dec 23, 2022
Understudied Drugs Administered to Children Per Standard of Care
Completed
- Adenovirus
- +58 more
- The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
-
Anchorage, Alaska
- +51 more
Dec 18, 2019
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntington Beach, California
- +139 more
Sep 3, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntsville, Alabama
- +163 more
Sep 3, 2018